PD
MBOT icon

Point72 (DIFC)’s Microbot Medical MBOT Stock Holding History

Point72 (DIFC)’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$744 Buy
+244
New +$761 ﹤0.01% 1065

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Point72 (DIFC)'s MBOT Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Microbot Medical (MBOT) in Q3 2025: 244 shares worth $744. The stake represents ﹤0.01% of the portfolio and ranks #1065 among its holdings.

67 funds tracked by Wall St. Rank hold MBOT as of Q3 2025.

  • Point72 (DIFC) held 244 shares of Microbot Medical worth $744 as of Q3 2025.
  • Microbot Medical was a new Point72 (DIFC) position in Q3 2025.
  • Microbot Medical made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1065 holding.
  • 67 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.